La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Biora Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Biora Therapeutics..

Biora Therapeutics (NASDAQ:BIOR) Azioni, Catena delle Opzioni

Biora Therapeutics

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Biora Therapeutics Inc

BioRegenx Inc

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies Inc

Biorem Inc

Biora Therapeutics (BIOR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis ...

Biora Therapeutics: A Strong Buy on Robust Q1 Performance and Promising Drug Delivery Platforms

An announcement from Biora Therapeutics (BIOR) is now available. Biora Therapeutics, Inc. has announced encouraging preliminary results from its BT...

Biora Therapeutics Reports Promising BT-600 Trial Results

Biora Therapeutics (BIOR) has shared an announcement. Biora Therapeutics recently revealed promising supplemental data from its Phase 1 trial of BT...

Biora Therapeutics Advances Ulcerative Colitis Treatment with BT-600 Trial Success

Biora Therapeutics GAAP EPS of -$0.04 beats by $0.41, revenue of $0.32M

Biora Therapeutics (BIOR) just unveiled an update. Biora Therapeutics, Inc. has initiated a strategic financial maneuver involving a debt exchange ...

Biora Therapeutics Restructures Debt and Issues New Securities

Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Call Transcript

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Biora Therapeutics</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/bior-stock-quote/"><strong>BIOR</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Biora Therapeutics reported earnings per share of -4 cents. This was above the analyst estimate for EPS of -45 cents.</li><li>The company reported revenue of $318,000.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/bior-stock-earnings-biora-therapeutics-for-q2-of-2024/">BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Biora Therapeutics (BIOR – Research Report), with a pr...

Biora Therapeutics: Outperforming with Strong Q2 Financials and Clinical Advancements

Biora Therapeutics granted extension to regain compliance with Nasdaq

Biora Therapeutics stock falls as it looks to raise $3M via direct offering

BIOR

News

Health Care

Financing

Press Releases

Biora Therapeutics Announces Funding Agreement with Existing Investors

Earnings

Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Markets

Biora Therapeutics Announces Positive Nasdaq Listing Decision

Biora Therapeutics Achieves ISO 13485 Certification

Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024

Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Avalo Therapeutics

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

BioRestorative Therapies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Ensysce Biosciences

Galecto

Immuron Limited - American Depositary Shares

Immuron

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Mustang Bio

NKGen Biotech

BiomX

PharmaCyte Biotech

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

Senti Biosciences

Turnstone Biologics

T2 Biosystems

Vaccinex

Vincerx Pharma

XTL Biopharmaceuticals Ltd. - American Depositary Shares

Comments

Biora Therapeutics

Biora Therapeutics (BIOR) Opzioni

Biora Therapeutics (NASDAQ:BIOR) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO